| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 10/10/2001 | EP1140836A1 Amide compounds |
| 10/10/2001 | EP1140823A1 Glucagon antagonists/inverse agonists |
| 10/10/2001 | EP1140819A1 Alfa-sulfenimino acid derivatives |
| 10/10/2001 | EP1140818A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 10/10/2001 | EP1140815A1 Novel thio-aminotetralin compounds useful in pain management |
| 10/10/2001 | EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/10/2001 | EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 10/10/2001 | EP1140803A1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 10/10/2001 | EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 10/10/2001 | EP1140799A1 Novel propargylether derivatives |
| 10/10/2001 | EP1140796A1 Process for the preparation of aromatic carboxylic acid amides |
| 10/10/2001 | EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4 |
| 10/10/2001 | EP1140784A2 Ion channel modulating agents |
| 10/10/2001 | EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 10/10/2001 | EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 10/10/2001 | EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 10/10/2001 | EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia |
| 10/10/2001 | EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 10/10/2001 | EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 10/10/2001 | EP1140067A1 Antiviral method using mek inhibitors |
| 10/10/2001 | EP1140046A1 Use of a mek inhibitor for preventing transplant rejection |
| 10/10/2001 | EP1140045A2 Homer a new target of treating psychiatric disorders |
| 10/10/2001 | EP0923590B1 Combinatorial method of identifying potential polymerisation catalysts of the organometallic type |
| 10/10/2001 | EP0840726B1 Process for the preparation of 2-(6-substituted pyrid-2-yloxymethyl)phenylacetate |
| 10/10/2001 | EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 10/10/2001 | EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity |
| 10/10/2001 | CN1316986A Novel compounds |
| 10/10/2001 | CN1316426A Uracil compound and its appliance |
| 10/10/2001 | CN1316423A Liquid-phase fluorination process for chloromethyl pyridine compounds |
| 10/10/2001 | CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative |
| 10/10/2001 | CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound |
| 10/09/2001 | US6300519 Antivirally active heterocyclic azahexane derivatives |
| 10/09/2001 | US6300500 Preparation of pyridone derivatives using phthalimido containing starting material |
| 10/09/2001 | US6300352 For therapy of asthma |
| 10/09/2001 | US6300351 For inhibiting human immunodeficiency virus-1 (hiv-1) reverse transcriptase |
| 10/09/2001 | US6300345 Cyanoguanidines as cell proliferation inhibitors |
| 10/09/2001 | US6300330 Blood coagulation factor x inhibitors as anticoagulants |
| 10/09/2001 | US6300323 (Poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides |
| 10/09/2001 | CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators |
| 10/04/2001 | WO2001072728A2 Novel piperazine derivatives |
| 10/04/2001 | WO2001072726A1 Oxime derivatives for controlling undesired microorganisms and animal pests |
| 10/04/2001 | WO2001072709A1 Naphtalene derivatives and their pharmaceutical use |
| 10/04/2001 | WO2001072685A2 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | WO2001072673A1 Anthracene derivatives and organic electroluminescent devices made by using the same |
| 10/04/2001 | WO2001072309A2 Treatment of cerebrovascular disease |
| 10/04/2001 | WO2001072308A1 Composition and method for intervening neuronal death using sulfasalazine |
| 10/04/2001 | WO2001072291A2 Treatment of movement disorders with metabotropic glutamate receptor antagonist |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | US20010027203 Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist |
| 10/04/2001 | US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma |
| 10/04/2001 | US20010027201 Non-systemic control of parasites |
| 10/04/2001 | US20010027200 PPARgamma modulators |
| 10/04/2001 | US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias |
| 10/04/2001 | US20010027196 Adenosine receptor ligands and their use in the treatment of disease |
| 10/04/2001 | US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab |
| 10/04/2001 | US20010026890 Nonaqueous |
| 10/04/2001 | EP1138685A2 Process for preparing substituted pyridines |
| 10/04/2001 | EP1138673A2 Novel carbamates and ureas as modifiers of multi-drug resistance |
| 10/04/2001 | EP1138329A2 Composition containing 5-Methyl-1-phenyl-2-(1 H)-pyridone for reparation and prevention of fibrotic lesions |
| 10/04/2001 | EP1138328A1 Naphthalene derivatives as CNS drugs |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP0700399B1 36-derivatives of rifamycins and their use as antimicrobial agents |
| 10/04/2001 | EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 10/04/2001 | EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 10/04/2001 | DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 10/04/2001 | DE10015015A1 New oxyalkanimidoylphenyl-substituted N-(heterocyclyl)-alkanoamide derivatives, are bactericides, fungicides, insecticides, acaricides and nematocides, useful e.g. in plant or material protection or as antimycotic agents |
| 10/04/2001 | CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2404329A1 Treatment of cerebrovascular disease |
| 10/04/2001 | CA2404049A1 Treatment of movement disorders |
| 10/04/2001 | CA2403814A1 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | CA2402288A1 Naphtalene derivatives and their pharmaceutical use |
| 10/03/2001 | CN1315320A Ether and amide compounds as medicide for treating glycuresis and preparing process thereof |
| 10/03/2001 | CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates |
| 10/03/2001 | CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid |
| 10/03/2001 | CN1072213C Process for producing guanidine derivatives, intermediates therefor |
| 10/02/2001 | US6297401 A 3-nitrosalicylamide derivative effective against plant pytopathogens |
| 10/02/2001 | US6297382 Compound and process for producing β-adrenergic receptor agonist |
| 10/02/2001 | US6297375 4-phenyl-pyridine derivatives |
| 10/02/2001 | US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them |
| 10/02/2001 | US6297287 Substituted trialkylenetetramines or n,n'-bis(pyridinylalkyl)alkylenediamines |
| 10/02/2001 | US6297283 Excellent inhibitory effect on the production of an ige antibody and are hence useful as antiallergic agents |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297276 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 10/02/2001 | US6297264 E.g., 4-(2-benzyloxy-2-(3-cyclopentyloxy-4-methoxyphenyl)ethyl)pyrid ine; phosphodiesterase inhibitors |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | US6297197 4-aminopicolinates and their use as herbicides |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 09/30/2001 | CA2342571A1 Process for preparing substituted pyridines |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 09/27/2001 | WO2001070733A2 Di-substituted iminoheterocyclic compounds |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070694A1 Amorphous torasemide modification |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |